Beyond its immunomodulatory effects, our study also uncovered a strong correlation between elevated CTSZ expression and increased TMB, particularly TP53 mutations, which are well known to contribute to genomic instability and tumor progression. This evidence concerns the gene CTSZ and neoplasm.